Chief of staff volunteer roles in teignmouth, devon

PCR at a glance 

In just a few short years we have achieved remarkable growth, expanding our income threefold from £1.5 million to £4.9 million in 2023-24 and have sustained this income in 2024-25. This growth reflects not only the urgency and importance of our mission but also the unwavering commitment of our team, trustees, and supporters who share our determination to fight prostate cancer and support the people it affects.

Guided by our vision to transform lives affected by prostate cancer, we remain committed to driving meaningful impact across our four core areas of focus:

Academic Research 

In 2024 we launched two new grant calls to tackle critical areas of unmet need: racial disparities in prostate cancer outcomes and advancements in treating bone metastases. These initiatives have continued our tradition of supporting cutting-edge research that transforms patient care and improves survival rates.

Translational Research  

Building on our success in bridging the gap between scientific discovery and real-world application, we have expanded our translational research portfolio to seven active projects. By fostering collaborations with biotech companies and research institutions, we will accelerate the development of groundbreaking diagnostics and treatments, ensuring they reach patients faster.

Influencing

Our influencing work has taken centre stage this year with the completion of our cost-benefit analysis, which has already generated significant interest. We have already launched this impactful analysis at an event at the House of Commons, at which we advocated for policy changes that prioritise early detection and equitable access to prostate cancer care. This initiative will help secure national commitment to advancing screening and diagnostic pathways.

We are now driving this campaign forward through lobbying and publicity as we aim to maximise on comms opportunities to raise the profile and awareness around the need for early detection.

Patient Projects

Empowering patients remains at the heart of everything we do. Following the success of our Infopool initiative, we will develop a follow-on project to enhance support for those living with prostate cancer. This new resource will build on the strengths of Infopool by providing even more tailored, accessible information to patients and their families with a focus on those most in need of better information. We have created truly groundbreaking projects that reach diverse communities, tackle deep-rooted challenges, and unlock the potential of scientists, advocates, and the communities we serve.

Prostate Cancer Research (“PCR”) is looking for up to three new Trustees to join our Board. We are specifically looking for people with the following experience:

 A Senior Comms professional. This trustee would potentially open doors with media outlets and help PCR to navigate and maximise the increased opportunities we have recently experienced. Examples include a long-standing campaign focused on screening for men that has been extensively featured in the Daily Mail. We now have further opportunities with potential TV ads and an awareness on the back of a prominent story in a popular soap.

A Senior Finance professional.  This trustee will have financial management experience (highly likely but not required to be a qualified accountant). They will bring financial expertise and experience to PCR’s activities and will be required to be part of our Finance Audit and Risk Committee.

A Translational Research/Data Analyst professional. This trustee will have translational research and/or Data Analyst expertise and will be capable of guiding strategic decisions and ensuring the organisation's research efforts are impactful and effective. This person would ideally have experience of spinning out a company or be well versed in the pharmaceutical industry.

A Senior HR professional. This trustee will have a track record of managing high performing teams in a growth environment. The Trustee will be a member of our People and Culture sub-committee, seeking to ensure staff are motivated by our vision & mission, enabling high retention and strong performance, alongside oversight of nominations, remuneration and policies. 

We would ideally find candidates that have some experience across two of the areas of experience.

We are committed to diversity, equality and inclusion as an organisation and seek to represent the patients and families we serve. To support this we would particularly welcome applications from women and members of the black community. 

The Opportunity  

Prostate Cancer Research’s Board comprises Trustees with experience across the medical sector, the pharmaceutical and biotech industry, charity governance, finance, fundraising and communications. We also ensure that the experience of prostate cancer patients is directly represented on our Board.

Our Board provides governance and oversight to ensure we are fulfilling our objectives. Its responsibilities are to:

• Contribute to the strategic direction of PCR, setting overall strategy, defining goals, setting targets and evaluating performance.

• Engage effectively as a Board to stimulate carefully considered and highquality strategic decision-making.

• Work in partnership with the CEO and Senior Management, helping them achieve the aims of PCR. 

• Act as an ambassador of PCR, to promote the charity and the importance of research into new treatments and diagnostics for prostate cancer patients.

• Provide governance oversight to ensure compliance with charity law and good practice.

• Safeguard the charity’s assets, including responsibility for its financial sustainability. 

In addition to the above, each Trustee uses specific skills, knowledge or experience they have to help the Board reach sound decisions. This may involve scrutinising Board papers, leading discussions, focusing on key issues, providing advice and guidance on new initiatives, or other issues in which the Trustee has expertise.

The Trustee Role and Responsibilities 

 Terms of the appointment:

• The Board meets four times per year.

• Meetings are held in person at PCR’s offices in London, with the option for Trustees to join meetings remotely depending on their location or availability. Candidates are expected to be UK-based. 

• In addition, Trustees often choose to provide advice and support to PCR’s Senior Management on specific projects and initiatives that are relevant to a Trustee’s areas of expertise. Involvement of this nature is discretionary and flexible, being respectful of Trustees other professional and personal commitments. 

• Trustees can also join a Board committee, which also meet four times per year ahead of the full board meeting. We have highlighted in the specs above which roles will be required to join a specific committee.

• This role is unremunerated, but reasonable, pre-agreed expenses will be reimbursed.

• The appointment is for an initial three-year term, with Trustees expected to serve for at least two terms. A third term is possible at the discretion of the Board.